We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

41 hedge funds and large institutions have $11.6M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,250% more call options, than puts

Call options by funds: $27K | Put options by funds: $2K

16% less funds holding

Funds holding: 49 → 41 (-8)

19% less capital invested

Capital invested by funds: $14.4M → $11.6M (-$2.8M)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

Holders
41
Holders Change
-8
Holders Change %
-16.33%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
11
Closed
11
Calls
$27K
Puts
$2K
Net Calls
+$25K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$431K
2
Renaissance Technologies
Renaissance Technologies
New York
+$177K
3
BFA
BlackRock Fund Advisors
California
+$6.52K
4
Citigroup
Citigroup
New York
+$6.52K
5
VKH
Virtu KCG Holdings
New York
+$5.22K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$958K
2
SGAM
Smith Group Asset Management
Texas
-$438K
3
AI
Ariel Investments
Illinois
-$201K
4
BCM
Bridgeway Capital Management
Texas
-$92K
5
Morgan Stanley
Morgan Stanley
New York
-$78.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$12K – – –
FNT
27
First National Trust
Pennsylvania
$8K – – –
NFA
28
Nationwide Fund Advisors
Ohio
$8K – – –
PPSG
29
Princeton Portfolio Strategies Group
New Jersey
$7K – – –
WEC
30
Winslow Evans & Crocker
Massachusetts
$6.48K – – –
Bank of America
31
Bank of America
North Carolina
$6K -$1.3K -1 -17%
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$6K +$3.91K +3 +300%
BFA
33
BlackRock Fund Advisors
California
$6K +$6.52K +5 New
Group One Trading
34
Group One Trading
Illinois
$5K -$6.52K -5 -56%
BMO
35
Beck Mack & Oliver
New York
$5K – – –
VKH
36
Virtu KCG Holdings
New York
$5K +$5.22K +4 New
UBS Group
37
UBS Group
Switzerland
$2K -$14.3K -11 -85%
First Manhattan
38
First Manhattan
New York
$2K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$2K +$2.61K +2 New
Morgan Stanley
40
Morgan Stanley
New York
$1K -$78.3K -60 -98%
Wells Fargo
41
Wells Fargo
California
$1K -$1.3K -1 Closed
PAM
42
Panagora Asset Management
Massachusetts
$1K – – –
RCM
43
RA Capital Management
Massachusetts
– -$958K -662 Closed
SGAM
44
Smith Group Asset Management
Texas
– -$438K -302 Closed
BCM
45
Bridgeway Capital Management
Texas
– -$92K -63 Closed
CCM
46
Condor Capital Management
New Jersey
– -$62K -43 Closed
HK
47
Horizon Kinetics
New York
– -$39K -27 Closed
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
– -$33K -23 Closed
NCCM
49
Nine Chapters Capital Management
New Jersey
– -$30K -21 Closed
SW
50
SVB Wealth
Massachusetts
– -$12K -8 Closed
1
2
3

FRTX Hedge Fund Activity: Q4 2015 in Review

41 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2015, worth a combined $11.6M — down 19% from $14.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FRTX and 3 opened new positions — a net loss of 8 holders — while 11 trimmed existing stakes and 5 added.

The largest buyer was Fidelity Investments, adding an estimated $431K. The largest seller was RA Capital Management, exiting entirely with an estimated $958K sold.

  • 41 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2015, down from 49 in Q3 2015.
  • Funds reported $11.6M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2015, down 19% quarter-over-quarter.
  • 3 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2015 and 11 closed out, a net change of -8 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2015 was Fidelity Investments, an estimated $431K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2015 was RA Capital Management, an estimated $958K sold.

Based on aggregated 13F filings for Q4 2015.